LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2.14 Cr | ₹-17 Cr | ₹9.21 Cr | ₹41 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of LASA SUPERGENERICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2024 | ₹2.14 Cr |
| Mar2023 | ₹-17 Cr |
| Mar2022 | ₹9.21 Cr |
| Mar2021 | ₹41 Cr |
| Mar2020 | ₹14 Cr |
How is Cash Flow from Operating Activities of LASA SUPERGENERICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹2.14 Cr | Positive | |
| Mar2023 | ₹-17 Cr | Negative | |
| Mar2022 | ₹9.21 Cr | -77.70 | |
| Mar2021 | ₹41 Cr | 203.24 | |
| Mar2020 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹47.3 Cr | -17.9% | 0.1% | -63.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -17.9% |
0.1% |
-63.5% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses